Program

Dr. Kimberly Struble is currently a Medical Team Leader in the Division of Antiviral Products at the Food and Drug Administration. She received a baccalaureate of Science in Pharmacy from the University of Connecticut and a Doctor of Pharmacy from the University of Arkansas for Medical Sciences. Dr Struble joined FDA in October 1993 and served in positions with Drug Information and the Division of Antiviral Products as a project manager and clinical reviewer. She left FDA in March 2002 to be the Director of US Regulatory Affairs and Director of Global research and development at Tibotec. In this capacity she was involved in the early development of two HIV compounds
She rejoined FDA in May 2003 as a clinical reviewer and is now a medical team leader in the Division of Antiviral Products. During her 16 year career, she has been involved in all phases of clinical drug development and leads a team responsible for  the development of new products for the treatment and prevention of HIV infection, hepatitis B and C, various herpes infections, and other emerging viral infections.  She is a member of the Department of Health and Human Services HIV Treatment Guidelines Panel. She serves on various committees including the executive committee for the Forum for Collaborative HIV Research and is the FDA representative to CDC for occupational and nonoccupational post-exposure prophylaxis public health service working group.
She has over 20 publications and 50 presentations relating to HIV drug development and FDA regulations.  In addition she is a volunteer clinical pharmacist at Whitman Walker Clinic in Washington DC.